BioSpace News Archive

Business

ACRO Members Heed the UK Government’s Call for Volunteers in Response to the COVID-19 Pandemic

In an effort to fight the global COVID-19 pandemic, over 150 employees from clinical research and technology organizations have volunteered to support United Kingdom government COVID-19 testing centres.

May 6, 2020
·
2 min read
Business

Eton Pharmaceuticals to Report First Quarter Financial Results on Thursday, May 14, 2020

Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, today announced that it will report first quarter 2020 financial and operating results on Thursday, May 14, 2020

May 6, 2020
·
1 min read
Business

ARCA Biopharma Announces First Quarter 2020 Financial Results And Provides Corporate Update

ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today reported financial results for the first quarter of 2020 and provided a corporate update.

May 6, 2020
·
6 min read
Business

Cellectis Provides Business Update and Reports Financial Results for First Quarter 2020

Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a clinical-stage biopharmaceutical company focused on developing immunotherapies based on allogeneic gene-edited CAR T-cells (UCART), today announced its results for the three-month period ended March 31, 2020.

May 6, 2020
·
24 min read
Business

Medicure Q1 2020 results and conference call dates

Medicure Inc. (“Medicure” or the “Company”) (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, will release financial results for the quarter ended March 31, 2020 on Tuesday, May 12, 2020.

May 6, 2020
·
1 min read
Drug Development

Tyvyt® Combined with Gemzar® and Platinum Chemotherapy Met the Predefined Primary Endpoint in the Phase 3 ORIENT-12 Study as First-Line Therapy in Patients with Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer

Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, autoimmune, metabolic and other major diseases, jointly announced with Eli Lilly and Company the results of a phase 3 study in China.

May 6, 2020
·
9 min read